GlaxoSmithKline Pharmaceuticals informs about updates
GlaxoSmithKline Pharmaceuticals has informed that the Company has received an Order dated 17th February 2026 for period April 2022 to March 2023 from Maharashtra GST authorities, raising a demand for Rs 6,92,76,478 in Maharashtra State.
The above information is a part of company’s filings submitted to BSE.
